Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11959080 Methods and compositions for inhibiting PMP22 expression

Patent 11959080 was granted and assigned to Ionis Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 17 Apr, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 17 Apr, 2024
Edits made to:
Infobox (+47 properties)
Article (+201 characters)
‌

 US Patent 11959080 Methods and compositions for inhibiting PMP22 expression

Article

Patent abstract

The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119590800
Patent Inventor Names
Eric E. Swayze0
Gene Hung0
Hien Thuy Zhao0
Holly Kordasiewicz0
Date of Patent
April 16, 2024
0
Patent Application Number
174931120
Date Filed
October 4, 2021
0
Patent Citations
‌
US Patent 11136577 Methods and compositions for inhibiting PMP22 expression
0
‌
US Patent 7399845 6-modified bicyclic nucleic acid analogs
0
‌
US Patent 7427672 Artificial nucleic acids of n-o bond crosslinkage type
0
‌
US Patent 7547684 5′-modified bicyclic nucleic acid analogs
0
‌
US Patent 7569686 Compounds and methods for synthesis of bicyclic nucleic acid analogs
0
‌
US Patent 7572582 Oligonucleotide analogues
0
‌
US Patent 7666854 Bis-modified bicyclic nucleic acid analogs
0
‌
US Patent 7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
0
‌
US Patent 7741457 6-modified bicyclic nucleic acid analogs
0
‌
US Patent 7750131 5′-modified bicyclic nucleic acid analogs
0
‌
US Patent 7875733 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
0
‌
US Patent 7939677 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
0
‌
US Patent 8022193 6-modified bicyclic nucleic acid analogs
0
‌
US Patent 8030467 5′-modified bicyclic nucleic acid analogs
0
‌
US Patent 8034909 Oligonucleotide analogues
0
‌
US Patent 8080644 Oligonucleotide analogues
0
‌
US Patent 8088746 Bis-modified bicyclic nucleic acid analogs
0
‌
US Patent 8088904 Tetrahydropyran nucleic acid analogs
0
‌
US Patent 8124745 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
0
‌
US Patent 8153365 Oligonucleotide analogues
0
‌
US Patent 8268980 5′-modified bicyclic nucleic acid analogs
0
‌
US Patent 8278283 6-disubstituted or unsaturated bicyclic nucleic acid analogs
0
‌
US Patent 8278425 None
0
‌
US Patent 8278426 Carbocyclic bicyclic nucleic acid analogs
0
‌
US Patent 8440803 Tetrahydropyran nucleic acid analogs
0
‌
US Patent 8501805 Substituted alpha-L-bicyclic nucleosides
0
‌
US Patent 8530640 Bicyclic cyclohexitol nucleic acid analogs
0
‌
US Patent 8546556 Carbocyclic alpha-L-bicyclic nucleic acid analogs
0
‌
US Patent RE44779 Bicyclonucleoside and oligonucleotide analogues
0
‌
US Patent 8796437 Tetrahydropyran nucleic acid analogs
0
‌
US Patent 9005906 Tetrahydropyran nucleic acid analogs
0
‌
US Patent 9012421 Bicyclic cyclohexose nucleic acid analogs
0
‌
US Patent 7034133 Oligonucleotide analogues
0
‌
US Patent 7053207 L-ribo-LNA analogues
0
Patent Primary Examiner
‌
Sean McGarry
0

Find more entities like US Patent 11959080 Methods and compositions for inhibiting PMP22 expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.